Matheus Bernardon Morillos

Matheus Bernardon Morillos

Auto-generated profile, based on publicly available information

Matheus Bernardon Morillos

Centro de Tratamento de Epilepsia Refratária (CETER), Hospital de Clínicas de Porto Alegre, Porto Alegre 90035-903 RS, Brazil; Neurology Department, Hospital Mãe de Deus, Porto Alegre 90880-481 RS, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2024 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
MMMatheus Bernardon Morillos
Matheus Bernardon Morillos
WBWyllians Vendramini Borelli
Wyllians Vendramini Borelli
GNGiovani Noll
Giovani Noll
CPCristian Daniel Piccini
Cristian Daniel Piccini
MLMartim Bravo Leite
Martim Bravo Leite
CTCarolina Machado Torres
Carolina Machado Torres
Background Autoimmune encephalitis (AE) consists of a group of acquired diseases that affect the central nervous system. A myriad of phenotypes may be present at the onset. Due to the heterogeneity of clinical presentations, it is difficult to achieve uniformity for the diagnostic and therapeutic processes and follow-up strategies. Objective To describe a series of patients diagnosed with AE in a resource-limited public hospital in southern Brazil and to analyze therapeutics and outcomes. Methods We retrospectively reviewed the electronic medical records of patients diagnosed with AE at the Hospital de Clínicas de Porto Alegre from 2014 to 2022. Data collected included clinical presentation, neuroimaging, cerebrospinal fluid testings, electroencephalogram, autoantibodies, treatments, outcomes, follow-up time, degree of neurological impairment, and mortality. Results Data from 17 patients were retrieved. Eleven cases were classified as definite AE and 6 as possible AE. Autoantibodies were identified in 9 patients. Timing for diagnosis was impacted by the high costs associated with autoantibody testing. Most patients became functionally dependent (82.4%) and most survivors remained with autoimmune-associated epilepsy (75%). Five patients died during hospitalization, and one after a 26-month of follow-up. Conclusion In this resource-limited hospital, patients with AE had a worse clinical outcome than that previously described in the literature. Development of epilepsy during follow-up and mortality were greater, whilst functional outcome was inferior. Autoantibody testing was initially denied in most patients, which impacted the definitive diagnosis and the use of second-line therapies.

10 December 2025 in Epilepsy & Behavior
Verified
Journal Article
Closed access
GCGeorge Vasconcelos Calheiros de Oliveira Costa
George Vasconcelos Calheiros de Oliveira Costa
ACAna Leticia Fornari Caprara
Ana Leticia Fornari Caprara
Jamir Pitton RissardoJamir Pitton Rissardo
Jamir Pitton Rissardo
AMAlba Letícia Peixoto Medeiros
Alba Letícia Peixoto Medeiros
MMMatheus Bernardon Morillos
Matheus Bernardon Morillos
MBMarino Muxfeldt Bianchin
Marino Muxfeldt Bianchin

22 November 2024 in neurogenetics
Verified
Journal Article
Closed access
PDF file
ÁFÁlvaro de Oliveira Franco
Álvaro de Oliveira Franco
MMMatheus Bernardon Morillos
Matheus Bernardon Morillos
MLMartim Tobias Bravo Leite
Martim Tobias Bravo Leite
MBMarino Muxfeldt Bianchin
Marino Muxfeldt Bianchin
CTCarolina Machado Torres
Carolina Machado Torres

1 January 2024 in Clinical and Biomedical Research
Verified
Journal Article
Open access
PDF file
GNGiovani Noll
Giovani Noll
TSTahiane de Brum Soares
Tahiane de Brum Soares
JDJuliana Avila Duarte
Juliana Avila Duarte
MMMatheus Bernardon Morillos
Matheus Bernardon Morillos
FSFernando Augusto Marion Spengler
Fernando Augusto Marion Spengler
JSJonas Alex Morales Saute
Jonas Alex Morales Saute
Introduction: Multiple sclerosis may rarely present alongside idiopathic thrombocytopenic purpura and scarcely ever following splenectomy for hematologic disease. Methods and Results: We report the case of a 51-year-old woman presenting with subacute onset of mild ataxia, dysarthria and lower limb dysesthesia in close temporal relationship with splenectomy performed as a treatment for steroid-dependent idiopathic thrombocytopenic purpura. MRI showed hyperintense T2/FLAIR multifocal white-matter lesions and there were highly positive cerebrospinal-fluid oligoclonal bands, picturing her first clinical episode of multiple sclerosis. She was treated with intravenous methylprednisolone, with significant improvement, and then started on multiple sclerosis disease-modifying therapy. Conclusion: This report suggests the possible role of splenectomy as an environmental trigger for clinical multiple sclerosis in genetically predisposed individuals, as well as for those with radiologically isolated syndrome. Introdução: A esclerose múltipla pode raramente apresentar-se em concomitância com a púrpura trombocitopênica idiopática e, excepcionalmente, após esplenectomia por doença hematológica. Métodos e Resultados: Relatamos o caso de uma mulher de 51 anos que apresentou início subagudo de ataxia leve, disartria e disestesia de membros inferiores em estreita relação temporal com esplenectomia realizada como tratamento para púrpura trombocitopênica idiopática cortico-dependente. A ressonância magnética mostrou lesões multifocais hiperintensas na substância branca em T2/FLAIR e foi evidenciada a presença de bandas oligoclonais exclusivas no líquor, caracterizando seu primeiro surto clínico de esclerose múltipla. Foi tratada com metilprednisolona intravenosa, com melhora significativa, e posteriormente submetida a terapia modificadora da doença para esclerose múltipla. Conclusão: Este relato de caso sugere o possível papel da esplenectomia como gatilho para o desencadeamento de esclerose múltipla clinicamente manifesta em indivíduos geneticamente predispostos, bem como para aqueles com síndrome radiologicamente isolada.